TY  - GEN
AU  - Jacquemot,L
AU  - Catelin,C
AU  - Dobrzynski,M
AU  - de Parscau,L
AU  - Sizun,J
TI  - [Prevention of community-acquired respiratory syncytial virus infections in premature infants: cost-benefit evaluation in the Finistère Department]
SN  - 0929-693X
PY  - 2002///0412
KW  - Age Factors
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Bronchopulmonary Dysplasia
KW  - complications
KW  - Community-Acquired Infections
KW  - prevention & control
KW  - Cost-Benefit Analysis
KW  - Double-Blind Method
KW  - France
KW  - Hospitalization
KW  - Humans
KW  - Immunization, Passive
KW  - Infant
KW  - Infant, Newborn
KW  - Infant, Premature, Diseases
KW  - economics
KW  - Multicenter Studies as Topic
KW  - Palivizumab
KW  - Placebos
KW  - Prospective Studies
KW  - Randomized Controlled Trials as Topic
KW  - Respiratory Syncytial Virus Infections
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Seasons
KW  - Time Factors
N1  - Publication Type: Comparative Study; Letter
UR  - https://doi.org/10.1016/s0929-693x(01)00734-5
ER  -